Nanox Receives FDA Clearance for HealthFLD, an Advanced AI-Based Software Empowering Clinicians in Assessment of Fatty Liver

Go back to Nanox Receives FDA Clearance for HealthFLD, an Advanced AI-Based Software Empowering Clinicians in Assessment of Fatty Liver
(NASDAQ: NNOX) Delayed: 1.62 -0.05 (2.99%)
Previous Close $1.67    52 Week High
Open $1.68    52 Week Low
Day High $1.69    P/E N/A 
Day Low $1.61    EPS
Volume 1,470,904